Back to News
Market Impact: 0.25
HealthTab™ Programme Expands Nationally Across England
Source: globenewswire.com
Company FundamentalsProduct LaunchesHealthcare & Biotech
Avricore Health announced NHS England has confirmed a national expansion of the Barts Health pharmacy cholesterol testing program, powered by Avricore’s HealthTab™ platform. The update is a positive commercialization milestone that should support future revenue visibility, though the financial impact ($/share) is not specified.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.35
Ticker Sentiment
AVCR0.75
AVCRF0.75
More News
- ‘I told you so’: China’s chip sector is making breakthroughs—and U.S. export controls are the reasons why
- CoreWeave credit default swaps hit distress levels as investors sour on AI debt
- The IPO drought is driving private equity-owned companies to the debt market to pay investors
- Hybe shares jump 10% as K-pop sensation BTS' tour lifts earnings hopes
- Giant Taiwanese chipmaker TSMC confirms it’s in talks with Elon Musk to join ‘Terafab’ complex in Texas: ‘The AI market continues to be very strong’
- EU Seeks New Trade Powers to Cut Trade Deficit